Lack of Correlation between Epidermal Growth Factor Receptor Status and Response to Panitumumab Monotherapy in Metastatic Colorectal Cancer (vol 16, pg 2205, 2010)

被引：0
|
作者：
Hecht, J. R.
Mitchell, E.
Neubauer, M. A.
Burris, H. A., III
Swanson, P.
Lopez, T.
Buchanan, G.
Reiner, M.
Gansert, J.
Jordan, B.
机构：
来源：
CLINICAL CANCER RESEARCH | 2010年 / 16卷 / 10期
关键词：
D O I：
10.1158/1078-0432.CCR-10-0766
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2917 / 2917
页数：1
相关论文
共 50 条
  • [1] Lack of Correlation between Epidermal Growth Factor Receptor Status and Response to Panitumumab Monotherapy in Metastatic Colorectal Cancer
    Hecht, J. Randolph
    Mitchell, Edith
    Neubauer, Marcus A.
    Burris, Howard A., III
    Swanson, Paul
    Lopez, Timothy
    Buchanan, Glenn
    Reiner, Maureen
    Gansert, Jennifer
    Berlin, Jordan
    [J]. CLINICAL CANCER RESEARCH, 2010, 16 (07) : 2205 - 2213
  • [2] Panitumumab and inhibition of the epidermal growth factor receptor signaling in the treatment of metastatic colorectal cancer
    Wyrwicz, Lucjan S.
    Nowecki, Zbigniew I.
    [J]. ONCOLOGY IN CLINICAL PRACTICE, 2010, 6 (06): : 290 - 300
  • [3] Panitumumab in metastatic colorectal cancer patients with low/negative epidermal growth factor receptor levels
    Mitchell, E.
    Hecht, J.
    Baranda, J.
    Malik, I
    Richards, D.
    Navale, L.
    D'Avirro, P.
    Amado, R.
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : 29 - 29
  • [4] Panitumumab activity in metastatic colorectal cancer patients with ≥10% epidermal growth factor receptor levels
    Chan, E.
    Neubauer, M.
    Swanson, P.
    Harker, W.
    Burris, H.
    Hecht, J.
    Navale, L.
    Brown, J.
    Amado, R.
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : 68 - 68
  • [5] Correlation between the response to cetuximab alone or in combination with irinotecan and the activated/phosphorylated epidermal growth factor receptor in metastatic colorectal cancer
    Personeni, N
    Hendlisz, A
    Gallez, J
    Galdon, MG
    Larsimont, D
    Van Laethem, JL
    Nagy, N
    Barette, M
    Paesmans, M
    Cardoso, F
    Bleiberg, H
    [J]. SEMINARS IN ONCOLOGY, 2005, 32 (06) : S59 - S62
  • [6] Epidermal Growth Factor Receptor-Targeted Therapy of Colorectal Cancer with Panitumumab
    Sartore-Bianchi, Andrea
    Sporchia, Andrea
    Cerea, Giulio
    Maugeri, Maria Rosaria
    Cipani, Tiziana
    Andreotti, Ines
    Marrapese, Giovanna
    Artale, Salvatore
    Siena, Salvatore
    [J]. CURRENT CANCER THERAPY REVIEWS, 2007, 3 (04) : 249 - 254
  • [7] Anti-Epidermal Growth Factor Receptor Monotherapy in the Treatment of Metastatic Colorectal Cancer: Where Are We Today? (vol 14, pg 29, 2009)
    Peeters, Marc
    Price, Tim
    Van Laethem, Jean-Luc
    [J]. ONCOLOGIST, 2009, 14 (03): : 307 - 307
  • [8] Epidermal growth factor receptor gene copy number and clinical outcome of metastatic colorectal cancer treated with panitumumab
    Sartore-Bianchi, Andrea
    Moroni, Mauro
    Veronese, Silvio
    Carnaghi, Carlo
    Bajetta, Emilio
    Luppi, Gabriele
    Sobrero, Alberto
    Barone, Carlo
    Cascinu, Stefano
    Colucci, Giuseppe
    Cortesi, Enrico
    Nichelatti, Michele
    Gambacorta, Marcello
    Siena, Salvatore
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (22) : 3238 - 3245
  • [9] Targeting the epidermal growth factor receptor in metastatic colorectal cancer
    Ng, Kimmie
    Zhu, Andrew X.
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2008, 65 (01) : 8 - 20
  • [10] KRAS mutational status is associated with clinical response in patients with metastatic colorectal cancer receiving panitumumab monotherapy
    Freeman, Dan
    Juan, Todd
    Meropo, Neal J.
    Hecht, J. Randolph
    Berlin, Jordan
    Van Cutsem, Eric
    Reiner, Maureen
    Radinsky, Robert
    Amado, Rafael G.
    Peeters, Marc
    [J]. MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3470S - 3470S
12345